Investors may fall for the gambler’s fallacy, assuming markets are “due” for a drop after strong gains. Jeff Schulze of ...
SGDJ targets junior gold stocks with strong revenue growth and stock price momentum, offering attractive valuations. Read why ...
Newton emphasizes the importance of continuing to “favor large-cap growth and trade momentum” rather than immediately shifting focus to mean reversion — our word of the day. Blikre ...
Wolfe Research initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating and $19 price target After its IPO in September 2024, the ...
That philosophy and a wide scope allow it to capitalize on mean reversion across the market, a unique advantage that should drive stronger long-term performance than the category index.
Attributed to Benjamin Graham While the S&P 500 had a robust total return of 25% in 2024, looking at longer-term annualized returns can help indicate if stocks might be at risk of mean reversion ...